News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Helen Y. Lee, PharmD, MBA

Articles by Helen Y. Lee, PharmD, MBA

Concern Still Warranted: Medication Burden and Persistence with Lipid-Lowering Drugs

ByJennifer M. Polinski, MPS, MS,Joshua J. Gagne, PharmD, MS. Reply by Teisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu J. Wang, PhD, MPH,Fadia T. Shaya, PhD, MPS,Helen Y. Lee, PharmD, MBA

December 31st 2008

Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension

ByTeisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu Wang, PhD,Fadia T. Shaya, PhD, MPH,Helen Y. Lee, PharmD, MBA

November 14th 2008

This study assesses the effect of medication burden on persistent use of newly added lipid-lowering drugs among patients with hypertension.

Latest Updated Articles

Concern Still Warranted: Medication Burden and Persistence with Lipid-Lowering Drugs
December 31st 2008
Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension
November 14th 2008

Trending on AJMC

5 August FDA Approvals Marked by Novelty, Pushback

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

Cross-Trial Vitiligo Data: What Payers Can and Can't Compare

Counseling Vitiligo Patients on Time to Repigmentation